Striated muscle function, regeneration, and repair

Cellular and Molecular Life Sciences

Volumn 73, Issue 22, 2016, Pages 4175-4202

  Shadrin, I Y ^a   Khodabukus, A ^a   Bursac, N ^a  

^a Duke University   (United States)

Author keywords

Cardiac; iPS; Muscle; Skeletal; Stem cells; Tissue engineering

Indexed keywords

BIOMATERIAL; CALCIUM CHANNEL; MOLECULAR SCAFFOLD; MYOD PROTEIN; MYOGENIC FACTOR 5; RYANODINE RECEPTOR; TRANSCRIPTION FACTOR PAX7;

CARDIAC MUSCLE; CARDIAC STEM CELL; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE CONTRACTION; MUSCLE REGENERATION; MYOBLAST; MYOBLAST TRANSPLANTATION; NEUROPHYSIOLOGICAL RECRUITMENT; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PERICYTE; PLURIPOTENT STEM CELL; REVIEW; SARCOPENIA; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; STEM CELL TRANSPLANTATION; STRIATED MUSCLE; TISSUE ENGINEERING; TISSUE REPAIR; TRANSVERSE TUBULAR SYSTEM; ULTRASTRUCTURE; VASCULARIZATION; ANIMAL; BIOLOGICAL MODEL; MUSCULAR DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; WOUND HEALING;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; MUSCLE, STRIATED; MUSCULAR DISEASES; REGENERATION; TISSUE ENGINEERING; WOUND HEALING;

EID: 84990190347     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2285-z     Document Type: Review

References (348)

1. Schiaffino S, Reggiani C (2011) Fiber types in mammalian skeletal muscles. Physiol Rev 91:1447–1531
2. Janssen I, Heymsfield SB, Wang ZM, Ross R (1985) Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 2000(89):81–88
3. Arnold HD (1899) Weight of the “Normal” Heart in Adults. J Boston Soc Med Sci 3:174–184
4. Dumont NA, Wang YX, Rudnicki MA (2015) Intrinsic and extrinsic mechanisms regulating satellite cell function. Development 142:1572–1581
5. Uygur A, Lee RT (2016) Mechanisms of Cardiac Regeneration. Dev Cell 36:362–374
6. Wallace GQ, McNally EM (2009) Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol 71:37–57
7. DiMauro S, Spiegel R (2011) Progress and problems in muscle glycogenoses. Acta Myol 30:96–102
8. Grogan BF, Hsu JR (2011) Skeletal trauma research C. Volumetric muscle loss. J Am Acad Orthop Surg 19(Suppl 1):S35–S37
9. Mann CJ, Perdiguero E, Kharraz Y, Aguilar S, Pessina P, Serrano AL et al (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1:21
10. Jessup M, Brozena S (2003) Heart failure. N Engl J Med 348:2007–2018
11. Fahed AC, Gelb BD, Seidman JG, Seidman CE (2013) Genetics of congenital heart disease: the glass half empty. Circ Res 112:707–720
12. Hanson J, Huxley HE (1953) Structural basis of the cross-striations in muscle. Nature 172:530–532
13. Huxley HE (1953) Electron microscope studies of the organisation of the filaments in striated muscle. Biochim Biophys Acta 12:387–394
14. Luther PK (2009) The vertebrate muscle Z-disc: sarcomere anchor for structure and signalling. J Muscle Res Cell Motil 30:171–185
15. Knöll R, Buyandelger B, Lab M (2011) The sarcomeric Z-disc and Z-discopathies. J Biomed Biotechnol 2011:569628
16. Al-Qusairi L, Laporte J (2011) T-tubule biogenesis and triad formation in skeletal muscle and implication in human diseases. Skelet Muscle 1:26
17. Fill M, Copello JA (2002) Ryanodine receptor calcium release channels. Physiol Rev 82:893–922
18. Schiaffino S, Margreth A (1969) Coordinated development of the sarcoplasmic reticulum and T system during postnatal differentiation of rat skeletal muscle. J Cell Biol 41:855–875
19. Franzini-Armstrong C, Ferguson DG, Champ C (1988) Discrimination between fast- and slow-twitch fibres of guinea pig skeletal muscle using the relative surface density of junctional transverse tubule membrane. J Muscle Res Cell Motil 9:403–414
20. Sawada K, Kawamura K (1991) Architecture of myocardial cells in human cardiac ventricles with concentric and eccentric hypertrophy as demonstrated by quantitative scanning electron microscopy. Heart Vessels 6:129–142
21. Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY et al (2013) Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA 110:1446–1451
22. Soonpaa MH, Kim KK, Pajak L, Franklin M, Field LJ (1996) Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271:H2183–H2189
23. Venable JH (1966) Constant cell populations in normal, testosterone-deprived and testosterone-stimulated levator ani muscles. Am J Anat 119:263–270
24. Enesco M, Puddy D (1964) Increase in the Number of Nuclei and Weight in Skeletal Muscle of Rats of Various Ages. Am J Anat 114:235–244
25. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA (2007) Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293:H1883–H1891
26. Souders CA, Borg TK, Banerjee I, Baudino TA (2012) Pressure overload induces early morphological changes in the heart. Am J Pathol 181:1226–1235
27. Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S et al (2015) Dynamics of cell generation and turnover in the human heart. Cell 161:1566–1575
28. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’Antoni ML, Debuque R et al (2016) Revisiting cardiac cellular composition. Circ Res 118:400–409
29. Gaudesius G, Miragoli M, Thomas SP, Rohr S (2003) Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93:421–428
30. McSpadden LC, Kirkton RD, Bursac N (2009) Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level. Am J Physiol Cell Physiol 297:C339–C351
31. Rohr S (2012) Arrhythmogenic implications of fibroblast-myocyte interactions. Circ Arrhyth Electrophysiol 5:442–452
32. Ongstad E, Kohl P (2016) Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions. J Mol Cell Cardiol 91:238–246
33. Bourdeau-Martini J, Odoroff CL, Honig CR (1974) Dual effect of oxygen on magnitude and uniformity of coronary intercapillary distance. Am J Physiol 226:800–810
34. Korthuis RJ (2011) Skeletal Muscle Circulation. San Rafael
35. Andersen P, Kroese AJ (1978) Capillary supply in soleus and gastrocnemius muscles of man. Pflugers Arch 375:245–249
36. Poole DC, Mathieu-Costello O (1989) Skeletal muscle capillary geometry: adaptation to chronic hypoxia. Respir Physiol 77:21–29
37. Poole DC, Mathieu-Costello O (1990) Analysis of capillary geometry in rat subepicardium and subendocardium. Am J Physiol 259:H204–H210
38. 2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies. Am J Physiol 276:H9–H18
39. Henneman E, Somjen G, Carpenter DO (1965) Excitability and inhibitability of motoneurons of different sizes. J Neurophysiol 28:599–620
40. Huxley AF (1957) Muscle structure and theories of contraction. Prog Biophys Biophys Chem 7:255–318
41. Allen DG, Kentish JC (1985) The cellular basis of the length-tension relation in cardiac muscle. J Mol Cell Cardiol 17:821–840
42. Granzier HL, Irving TC (1995) Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys J 68:1027–1044
43. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9:493–495
44. Lepper C, Partridge TA, Fan CM (2011) An absolute requirement for Pax7-positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 138:3639–3646
45. Sambasivan R, Comai G, Le Roux I, Gomes D, Konge J, Dumas G et al (2013) Embryonic founders of adult muscle stem cells are primed by the determination gene Mrf4. Dev Biol 381:241–255
46. Biressi S, Bjornson CR, Carlig PM, Nishijo K, Keller C, Rando TA (2013) Myf5 expression during fetal myogenesis defines the developmental progenitors of adult satellite cells. Dev Biol 379:195–207
47. Kuang S, Kuroda K, Le Grand F, Rudnicki MA (2007) Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129:999–1010
48. Cossu G, Tajbakhsh S (2007) Oriented cell divisions and muscle satellite cell heterogeneity. Cell 129:859–861
49. Gunther S, Kim J, Kostin S, Lepper C, Fan CM, Braun T (2013) Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Cell Stem Cell 13:590–601
50. Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209–238
51. Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93:23–67
52. Leri A, Rota M, Pasqualini FS, Goichberg P, Anversa P (2015) Origin of cardiomyocytes in the adult heart. Circ Res 116:150–166
53. + Progenitor Cells Are an Irrelevant Source of Cardiac Myocytes In Vivo. Circ Res 118:17–19
54. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A et al (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204:1057–1069
55. Madaro L, Bouche M (2014) From innate to adaptive immune response in muscular dystrophies and skeletal muscle regeneration: the role of lymphocytes. Biomed Res Int 2014:438675
56. Aurora AB, Olson EN (2014) Immune modulation of stem cells and regeneration. Cell Stem Cell 15:14–25
57. Webster MT, Manor U, Lippincott-Schwartz J, Fan CM (2016) Intravital Imaging Reveals Ghost Fibers as Architectural Units Guiding Myogenic Progenitors during Regeneration. Cell Stem Cell 18:243–252
58. Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B (2013) Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS J 280:4118–4130
59. Joe AW, Yi L, Natarajan A, Le Grand F, So L, Wang J et al (2010) Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 12:153–163
60. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM et al (2013) Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153:376–388
61. Foglia MJ, Poss KD (2016) Building and re-building the heart by cardiomyocyte proliferation. Development 143:729–740
62. Haubner BJ, Schneider J, Schweigmann U, Schuetz T, Dichtl W, Velik-Salchner C et al (2016) Functional recovery of a human neonatal heart after severe myocardial infarction. Circ Res 118:216–221
63. Xin M, Olson EN, Bassel-Duby R (2013) Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat Rev Mol Cell Biol 14:529–541
64. Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel-Duby R et al (2014) Macrophages are required for neonatal heart regeneration. J Clin Investig 124:1382–1392
65. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–2988
66. Morrison JI, Loof S, He P, Simon A (2006) Salamander limb regeneration involves the activation of a multipotent skeletal muscle satellite cell population. J Cell Biol 172:433–440
67. Poss KD, Keating MT, Nechiporuk A (2003) Tales of regeneration in zebrafish. Dev Dyn 226:202–210
68. Turner NJ, Badylak SF (2012) Regeneration of skeletal muscle. Cell Tissue Res 347:759–774
69. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52:80–85
70. Berger MJ, Doherty TJ (2010) Sarcopenia: prevalence, mechanisms, and functional consequences. Interdiscip Top Gerontol 37:94–114
71. Ryall JG, Schertzer JD, Lynch GS (2008) Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 9:213–228
72. Morse CI, Thom JM, Reeves ND, Birch KM, Narici MV (1985) In vivo physiological cross-sectional area and specific force are reduced in the gastrocnemius of elderly men. J Appl Physiol 2005(99):1050–1055
73. Hughes VA, Frontera WR, Wood M, Evans WJ, Dallal GE, Roubenoff R et al (2001) Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci 56:B209–B217
74. Porter MM, Vandervoort AA, Lexell J (1995) Aging of human muscle: structure, function and adaptability. Scand J Med Sci Sports 5:129–142
75. Cosgrove BD, Gilbert PM, Porpiglia E, Mourkioti F, Lee SP, Corbel SY et al (2014) Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat Med 20:255–264
76. Bernet JD, Doles JD, Hall JK (2014) Kelly Tanaka K, Carter TA, Olwin BB. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat Med 20:265–271
77. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease C et al (2014) CDC national health report: leading causes of morbidity and mortality and associated behavioral risk and protective factors–United States, 2005–2013. Morb Mort Week Rep Surveill Summ 63(Suppl 4):3–27
78. Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E (2006) Diagnosis and management of diastolic dysfunction and heart failure. Am Fam Physician 73:841–846
79. Yang Q, Chen H, Correa A, Devine O, Mathews TJ, Honein MA (2006) Racial differences in infant mortality attributable to birth defects in the United States, 1989–2002. Birth Defects Res A 76:706–713
80. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39:1890–1900
81. Avolio E, Caputo M, Madeddu P (2015) Stem cell therapy and tissue engineering for correction of congenital heart disease. Front Cell Dev Biol 3
82. Mercuri E, Muntoni F (2013) Muscular dystrophy: new challenges and review of the current clinical trials. Curr Opin Pediatr 25:701–707
83. Lapidos KA, Kakkar R, McNally EM (2004) The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 94:1023–1031
84. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S et al (2012) Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal Radiol 41:955–961
85. Khurana TS, Prendergast RA, Alameddine HS, Tome FM, Fardeau M, Arahata K et al (1995) Absence of extraocular muscle pathology in Duchenne’s muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 182:467–475
86. Goldstein JA, McNally EM (2010) Mechanisms of muscle weakness in muscular dystrophy. J General Physiol 136:29–34
87. Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ (2010) T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 255:899–908
88. Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L et al (2011) Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 76:346–353
89. McNally EM, Pytel P (2007) Muscle diseases: the muscular dystrophies. Annu Rev Pathol 2:87–109
90. Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M et al (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker’s muscular dystrophy. Circulation 94:3168–3175
91. Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovas Imaging 4:67–76
92. Mouly V, Aamiri A, Perie S, Mamchaoui K, Barani A, Bigot A et al (2005) Myoblast transfer therapy: is there any light at the end of the tunnel? Acta Myol 24:128–133
93. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A et al (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309:2064–2067
94. Machida S, Spangenburg EE, Booth FW (2004) Primary rat muscle progenitor cells have decreased proliferation and myotube formation during passages. Cell Prolif 37:267–277
95. Beauchamp JR, Morgan JE, Pagel CN, Partridge TA (1999) Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 144:1113–1121
96. Ono Y, Masuda S, Nam HS, Benezra R, Miyagoe-Suzuki Y, Takeda S (2012) Slow-dividing satellite cells retain long-term self-renewal ability in adult muscle. J Cell Sci 125:1309–1317
97. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeney HL, Discher DE (2004) Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 166:877–887
98. Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P et al (2010) Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329:1078–1081
99. Périé S, Trollet C, Mouly V, Vanneaux V, Mamchaoui K, Bouazza B et al (2014) Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study. Mol Ther 22:219–225
100. Barberi T, Bradbury M, Dincer Z, Panagiotakos G, Socci ND, Studer L (2007) Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13:642–648
101. Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M et al (2012) Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10:610–619
102. Darabi R, Santos FN, Filareto A, Pan W, Koene R, Rudnicki MA et al (2011) Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors. Stem Cells 29:777–790
103. Darabi R, Pan W, Bosnakovski D, Baik J, Kyba M, Perlingeiro RC (2011) Functional Myogenic Engraftment from Mouse iPS Cells. Stem Cell Rev 7:948–957
104. Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D et al (2014) Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Trans Med 3:149–160
105. Albini S, Coutinho P, Malecova B, Giordani L, Savchenko A, Forcales SV et al (2013) Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres. Cell Rep 3:661–670
106. Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, Gekas J et al (2012) Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol Ther 20:2153–2167
107. Shelton M, Metz J, Liu J, Carpenedo RL, Demers SP, Stanford WL et al (2014) Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rep 3:516–529
108. Borchin B, Chen J, Barberi T (2013) Derivation and FACS-mediated purification of PAX3 +/PAX7 + skeletal muscle precursors from human pluripotent stem cells. Stem Cell Reports. 1:620–631
109. Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A et al (2013) A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 155:909–921
110. Chal J, Oginuma M, Al Tanoury Z, Gobert B, Sumara O, Hick A et al (2015) Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nat Biotechnol 33:962–969
111. Relaix F, Weng X, Marazzi G, Yang E, Copeland N, Jenkins N et al (1996) Pw1, a novel zinc finger gene implicated in the myogenic and neuronal lineages. Dev Biol 177:383–396
112. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, Besson V, Gomes ER et al (2010) Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12:257–266
113. Arrighi N, Moratal C, Clement N, Giorgetti-Peraldi S, Peraldi P, Loubat A et al (2015) Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle. Cell Death Dis 6:e1733
114. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12:143–152
115. Mozzetta C, Consalvi S, Saccone V, Tierney M, Diamantini A, Mitchell KJ et al (2013) Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 5:626–639
116. Formicola L, Marazzi G, Sassoon DA (2014) The extraocular muscle stem cell niche is resistant to ageing and disease. Front Aging Neurosci 6:328
117. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M (2007) Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol 2 (Unit 2B 1)
118. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A et al (2002) The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129:2773–2783
119. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Cusella-De Angelis MG et al (1999) Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147:869–878
120. Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A et al (2013) Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 10:67–84
121. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, Perani L et al (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255–267
122. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS et al (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313
123. Tedesco FS, Cossu G (2012) Stem cell therapies for muscle disorders. Curr Opin Neurol 25:597–603
124. Tedesco FS, Gerli MF, Perani L, Benedetti S, Ungaro F, Cassano M et al (2012) Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Trans Med 4:140ra89
125. Sampaolesi M, Blot S, D’Antona G, Granger N, Tonlorenzi R, Innocenzi A et al (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574–579
126. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D’Antona G, Pellegrino MA et al (2003) Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301:487–492
127. Quattrocelli M, Swinnen M, Giacomazzi G, Camps J, Barthelemy I, Ceccarelli G et al (2015) Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. J Clin Investig 125:4463–4482
128. Bonfanti C, Rossi G, Tedesco FS, Giannotta M, Benedetti S, Tonlorenzi R et al (2015) PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence. Nat Commun. 6:6364
129. Alrefai MT, Murali D, Paul A, Ridwan KM, Connell JM, Shum-Tim D (2015) Cardiac tissue engineering and regeneration using cell-based therapy. Stem Cells Cloning Adv Appl 8:81–101
130. Wang X, Zhang J, Zhang F, Li J, Li Y, Tan Z et al (2015) The clinical status of stem cell therapy for ischemic cardiomyopathy. Stem Cells Int 2015:135023
131. Menasché P, Hagège AA, Scorsin M, Pouzet B, Desnos M, Duboc D et al (2001) Myoblast transplantation for heart failure. Lancet 357:279–280
132. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N et al (2004) Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148:531–537
133. Hagège AA, Marolleau JP, Vilquin JT, Alhéritière A, Peyrard S, Duboc D et al (2006) Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114:I108–I113
134. Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L et al (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial. First Randomized Placebo-Controlled Study of Myoblast Transplantation. Circulation
135. Duckers HJ, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A et al (2011) Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 6:805–812
136. Reinecke H, Murry CE (2000) Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 9:337–344
137. Farahmand P, Lai TY, Weisel RD, Fazel S, Yau T, Menasche P et al (2008) Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation 118:S130–S137
138. Shintani Y, Fukushima S, Varela-Carver A, Lee J, Coppen SR, Takahashi K et al (2009) Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol 47:288–295
139. Dimmeler S, Zeiher AM (2009) Cell therapy of acute myocardial infarction: open questions. Cardiology 113:155–160
140. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
141. Mizuno H, Tobita M, Uysal AC (2012) Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30:804–810
142. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551–568
143. Sadat K, Ather S, Aljaroudi W, Heo J, Iskandrian AE, Hage FG (2014) The effect of bone marrow mononuclear stem cell therapy on left ventricular function and myocardial perfusion. J Nuclear Cardiol Off Publ Am Soc Nuclear Cardiol 21:351–367
144. de Jong R, Houtgraaf JH, Samiei S, Boersma E, Duckers HJ (2014) Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovas Interven 7:156–167
145. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E (2014) Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev 4:CD007888
146. Terzic A, Behfar A (2014) Regenerative heart failure therapy headed for optimization. Eur Heart J
147. Nadal-Ginard B, Kajstura J, Leri A, Anversa P (2003) Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92:139–150
148. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F et al (2004) Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911–921
149. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E et al (2007) Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896–908
150. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S et al (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847–1857
151. Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO et al (2014) Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 63:110–122
152. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A et al (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Investig 108:407–414
153. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP et al (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30–e41
154. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, Freund C et al (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1:9–24
155. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A et al (2007) Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50:1884–1893
156. Laflamme MA, Gold J, Xu C, Hassanipour M, Rosler E, Police S et al (2005) Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167:663–671
157. Fernandes S, Naumova AV, Zhu WZ, Laflamme MA, Gold J, Murry CE (2010) Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol 49:941–949
158. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015–1024
159. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J et al (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489:322–325
160. Shiba Y, Filice D, Fernandes S, Minami E, Dupras SK, Biber BV et al (2014) Electrical Integration of Human Embryonic Stem Cell-Derived Cardiomyocytes in a Guinea Pig Chronic Infarct Model. J Cardiovas Pharmacol Therap
161. Ye L, Chang YH, Xiong Q, Zhang P, Zhang L, Somasundaram P et al (2014) Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15:750–761
162. Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ et al (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510:273–277
163. Jackman CP, Shadrin IY, Carlson AL, Bursac N (2015) Human Cardiac Tissue Engineering: from Pluripotent Stem Cells to Heart Repair. Curr Opin Chem Eng 7:57–64
164. Sicari BM, Rubin JP, Dearth CL, Wolf MT, Ambrosio F, Boninger M et al (2014) An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss. Sci Trans Med 6:234ra58
165. Keane TJ, Londono R, Turner NJ, Badylak SF (2012) Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 33:1771–1781
166. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF (2009) Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 30:1482–1491
167. Valentin JE, Stewart-Akers AM, Gilbert TW, Badylak SF (2009) Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15:1687–1694
168. Londono R, Badylak SF (2015) Biologic Scaffolds for Regenerative Medicine: Mechanisms of In vivo Remodeling. Ann Biomed Eng 43:577–592
169. Wolf MT, Daly KA, Reing JE, Badylak SF (2012) Biologic scaffold composed of skeletal muscle extracellular matrix. Biomaterials 33:2916–2925
170. Valentin JE, Turner NJ, Gilbert TW, Badylak SF (2010) Functional skeletal muscle formation with a biologic scaffold. Biomaterials 31:7475–7484
171. Corona BT, Ward CL, Baker HB, Walters TJ, Christ GJ (2014) Implantation of in vitro tissue engineered muscle repair constructs and bladder acellular matrices partially restore in vivo skeletal muscle function in a rat model of volumetric muscle loss injury. Tissue Eng Part A 20:705–715
172. Mase VJ, Jr., Hsu JR, Wolf SE, Wenke JC, Baer DG, Owens J et al (2010) Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 33
173. Aurora A, Garg K, Corona BT, Walters TJ (2014) Physical rehabilitation improves muscle function following volumetric muscle loss injury. BMC Sports Sci Med Rehabil 6:41
174. Scholl FG, Boucek MM, Chan KC, Valdes-Cruz L, Perryman R (2010) Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease. World J Pediat Congen Heart Surg 1:132–136
175. Okada M, Payne TR, Oshima H, Momoi N, Tobita K, Huard J (2010) Differential efficacy of gels derived from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 31:7678–7683
176. Toeg HD, Tiwari-Pandey R, Seymour R, Ahmadi A, Crowe S, Vulesevic B et al (2013) Injectable small intestine submucosal extracellular matrix in an acute myocardial infarction model. Ann Thorac Surg 96:1686–1694 (discussion 94)
177. Tan MY, Zhi W, Wei RQ, Huang YC, Zhou KP, Tan B et al (2009) Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30:3234–3240
178. Dai W, Gerczuk P, Zhang Y, Smith L, Kopyov O, Kay GL et al (2013) Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats. J Cardiovas Pharmacol Therap 18:270–279
179. Singelyn JM, Sundaramurthy P, Johnson TD, Schup-Magoffin PJ, Hu DP, Faulk DM et al (2012) Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. J Am Coll Cardiol 59:751–763
180. Seif-Naraghi SB, Singelyn JM, Salvatore MA, Osborn KG, Wang JJ, Sampat U et al (2013) Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction. Sci Transl Med 5:173ra25
181. Johnson TD, Christman KL (2013) Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction. Expert Opin Drug Deliv 10:59–72
182. Burdick JA, Mauck RL, Gorman JH, 3rd, Gorman RC (2013) Acellular biomaterials: an evolving alternative to cell-based therapies. Sci Trans Med 5:176ps4
183. Cohen JE, Purcell BP, MacArthur JW Jr, Mu A, Shudo Y, Patel JB et al (2014) A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy. Circ Heart Fail 7:619–626
184. Miyagi Y, Chiu LL, Cimini M, Weisel RD, Radisic M, Li RK (2011) Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 32:1280–1290
185. Miyagi Y, Zeng F, Huang XP, Foltz WD, Wu J, Mihic A et al (2010) Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials 31:7684–7694
186. Ungerleider JL, Christman KL (2014) Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress. Stem Cells Trans Med 3:1090–1099
187. Malliaras K, Marban E (2011) Cardiac cell therapy: where we’ve been, where we are, and where we should be headed. Br Med Bull 98:161–185
188. Bach AD, Beier JP, Stern-Staeter J, Horch RE (2004) Skeletal muscle tissue engineering. J Cell Mol Med 8:413–422
189. Rosso F, Giordano A, Barbarisi M, Barbarisi A (2004) From cell-ECM interactions to tissue engineering. J Cell Physiol 199:174–180
190. Even-Ram S, Artym V, Yamada KM (2006) Matrix control of stem cell fate. Cell 126:645–647
191. Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677–689
192. Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V et al (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290:H2196–H2203
193. Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S et al (2004) Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110:155–162
194. Light N, Champion AE (1984) Characterization of muscle epimysium, perimysium and endomysium collagens. Biochem J 219:1017–1026
195. Vandenburgh HH, Karlisch P, Farr L (1988) Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell Dev Biol 24:166–174
196. Shansky J, Del Tatto M, Chromiak J, Vandenburgh H (1997) A simplified method for tissue engineering skeletal muscle organoids in vitro. In Vitro Cell Dev Biol Anim 33:659–661
197. Okano T, Matsuda T (1998) Tissue engineered skeletal muscle: preparation of highly dense, highly oriented hybrid muscular tissues. Cell Transpl 7:71–82
198. Okano T, Matsuda T (1997) Hybrid muscular tissues: preparation of skeletal muscle cell-incorporated collagen gels. Cell Transpl 6:109–118
199. Okano T, Satoh S, Oka T, Matsuda T (1997) Tissue engineering of skeletal muscle. Highly dense, highly oriented hybrid muscular tissues biomimicking native tissues. ASAIO J 43:M749–M753
200. Lee PH, Vandenburgh HH (2013) Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system. Tissue Eng Part A 19:2147–2155
201. Vandenburgh H, Shansky J, Benesch-Lee F, Skelly K, Spinazzola JM, Saponjian Y et al (2009) Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts. FASEB J. 23:3325–3334
202. Vandenburgh H, Shansky J, Benesch-Lee F, Barbata V, Reid J, Thorrez L et al (2008) Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve 37:438–447
203. Mudera V, Smith AS, Brady MA, Lewis MP (2010) The effect of cell density on the maturation and contractile ability of muscle derived cells in a 3D tissue-engineered skeletal muscle model and determination of the cellular and mechanical stimuli required for the synthesis of a postural phenotype. J Cell Physiol 225:646–653
204. Brady MA, Lewis MP, Mudera V (2008) Synergy between myogenic and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle construct. Journal of tissue engineering and regenerative medicine. 2:408–417
205. Yan W, George S, Fotadar U, Tyhovych N, Kamer A, Yost MJ et al (2007) Tissue engineering of skeletal muscle. Tissue Eng 13:2781–2790
206. Close RI (1972) Dynamic properties of mammalian skeletal muscles. Physiol Rev 52:129–197
207. Collet JP, Shuman H, Ledger RE, Lee S, Weisel JW (2005) The elasticity of an individual fibrin fiber in a clot. Proc Natl Acad Sci USA 102:9133–9137
208. Chiron S, Tomczak C, Duperray A, Lainé J, Bonne G, Eder A et al (2012) Complex interactions between human myoblasts and the surrounding 3D fibrin-based matrix. PLoS One 7:e36173
209. Huang YC, Dennis RG, Larkin L, Baar K (2005) Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol 98:706–713
210. Juhas M, Engelmayr GC Jr, Fontanella AN, Palmer GM, Bursac N (2014) Biomimetic engineered muscle with capacity for vascular integration and functional maturation in vivo. Proc Natl Acad Sci USA 111:5508–5513
211. Hinds S, Bian W, Dennis RG, Bursac N (2011) The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle. Biomaterials 32:3575–3583
212. Juhas M, Bursac N (2014) Roles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cells. Biomaterials 35:9438–9446
213. Khodabukus A, Baar K (2015) Contractile and metabolic properties of engineered skeletal muscle derived from slow and fast phenotype mouse muscle. J Cell Physiol 230:1750–1757
214. Khodabukus A, Baar K (2009) Regulating Fibrinolysis to Engineer Skeletal Muscle from the C2C12 Cell Line. Tissue Eng Part C Methods 15:501–511
215. Madden L, Juhas M, Kraus WE, Truskey GA, Bursac N (2015) Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. Elife. 4:e04885
216. Strohman RC, Bayne E, Spector D, Obinata T, Micou-Eastwood J, Maniotis A (1990) Myogenesis and histogenesis of skeletal muscle on flexible membranes in vitro. In Vitro Cell Dev Biol 26:201–208
217. Dennis RG, Kosnik PE 2nd, Gilbert ME, Faulkner JA (2001) Excitability and contractility of skeletal muscle engineered from primary cultures and cell lines. Am J Physiol Cell Physiol 280:C288–C295
218. Nagamori E, Ngo TX, Takezawa Y, Saito A, Sawa Y, Shimizu T et al (2013) Network formation through active migration of human vascular endothelial cells in a multilayered skeletal myoblast sheet. Biomaterials 34:662–668
219. Takahashi H, Okano T (2015) Cell sheet-based tissue engineering for organizing anisotropic tissue constructs produced using microfabricated thermoresponsive substrates. Adv Healthc Mater. 4:2388–2407
220. Takahashi H, Shimizu T, Nakayama M, Yamato M, Okano T (2013) The use of anisotropic cell sheets to control orientation during the self-organization of 3D muscle tissue. Biomaterials 34:7372–7380
221. Khodabukus A, Baar K (2014) The effect of serum origin on tissue engineered skeletal muscle function. J Cell Biochem 115:2198–2207
222. Huang YC, Dennis RG, Baar K (2006) Cultured slow vs. fast skeletal muscle cells differ in physiology and responsiveness to stimulation. Am J Physiol Cellphysiol 291:C11–C17
223. Li M, Dickinson CE, Finkelstein EB, Neville CM, Sundback CA (2011) The role of fibroblasts in self-assembled skeletal muscle. Tissue Eng Part A 17:2641–2650
224. Hinds S, Tyhovych N, Sistrunk C, Terracio L (2013) Improved tissue culture conditions for engineered skeletal muscle sheets. Sci World J 2013:370151
225. Merceron TK, Burt M, Seol YJ, Kang HW, Lee SJ, Yoo JJ et al (2015) A 3D bioprinted complex structure for engineering the muscle-tendon unit. Biofabrication 7:035003
226. Ladd MR, Lee SJ, Stitzel JD, Atala A, Yoo JJ (2011) Co-electrospun dual scaffolding system with potential for muscle-tendon junction tissue engineering. Biomaterials 32:1549–1559
227. Larkin LM, Calve S, Kostrominova TY, Arruda EM (2006) Structure and functional evaluation of tendon-skeletal muscle constructs engineered in vitro. Tissue Eng 12:3149–3158
228. Kostrominova TY, Calve S, Arruda EM, Larkin LM (2009) Ultrastructure of myotendinous junctions in tendon-skeletal muscle constructs engineered in vitro. Histol Histopathol 24:541–550
229. VanDusen KW, Syverud BC, Williams ML, Lee JD, Larkin LM (2014) Engineered Skeletal Muscle Units for Repair of Volumetric Muscle Loss in the Tibialis Anterior Muscle of a Rat. Tissue Eng Part A
230. Das M, Rumsey JW, Bhargava N, Stancescu M, Hickman JJ (2010) A defined long-term in vitro tissue engineered model of neuromuscular junctions. Biomaterials 31:4880–4888
231. Guo X, Gonzalez M, Stancescu M, Vandenburgh HH, Hickman JJ (2011) Neuromuscular junction formation between human stem cell-derived motoneurons and human skeletal muscle in a defined system. Biomaterials 32:9602–9611
232. Morimoto Y, Kato-Negishi M, Onoe H, Takeuchi S (2013) Three-dimensional neuron-muscle constructs with neuromuscular junctions. Biomaterials 34:9413–9419
233. Larkin LM, Van der Meulen JH, Dennis RG, Kennedy JB (2006) Functional evaluation of nerve-skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim 42:75–82
234. Bian W, Bursac N (2012) Soluble miniagrin enhances contractile function of engineered skeletal muscle. FASEB J 26:955–965
235. Wang L, Shansky J, Vandenburgh H (2013) Induced formation and maturation of acetylcholine receptor clusters in a defined 3D bio-artificial muscle. Mol Neurobiol 48:397–403
236. Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ (2013) The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials 34:3246–3255
237. Olwin BB, Arthur K, Hannon K, Hein P, McFall A, Riley B et al (1994) Role of FGFs in skeletal muscle and limb development. Mol Reprod Dev 39:90–100 (discussion-1)
238. Tidball JG (2005) Mechanical signal transduction in skeletal muscle growth and adaptation. J Appl Physiol 98:1900–1908
239. Vandenburgh HH (1982) Dynamic mechanical orientation of skeletal myofibers in vitro. Dev Biol 93:438–443
240. Vandenburgh HH, Swasdison S, Karlisch P (1991) Computer-aided mechanogenesis of skeletal muscle organs from single cells in vitro. Faseb J. 5:2860–2867
241. Powell CA, Smiley BL, Mills J, Vandenburgh HH (2002) Mechanical stimulation improves tissue-engineered human skeletal muscle. Am J Physiol Cell Physiol 283:C1557–C1565
242. du Moon G, Christ G, Stitzel JD, Atala A, Yoo JJ (2008) Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng Part A 14:473–482
243. Harris AJ (1981) Embryonic growth and innervation of rat skeletal muscles. I. Neural regulation of muscle fibre numbers. Philos Trans R Soc Lond B Biol Sci 293:257–277
244. Duxson MJ, Sheard PW (1995) Formation of new myotubes occurs exclusively at the multiple innervation zones of an embryonic large muscle. Dev Dyn 204:391–405
245. Kern H, Boncompagni S, Rossini K, Mayr W, Fanò G, Zanin ME et al (2004) Long-term denervation in humans causes degeneration of both contractile and excitation-contraction coupling apparatus, which is reversible by functional electrical stimulation (FES): a role for myofiber regeneration? J Neuropathol Exp Neurol 63:919–931
246. Salmons S, Sreter FA (1976) Significance of impulse activity in the transformation of skeletal muscle type. Nature 263:30–34
247. Khodabukus A, Baar K (2015) Streptomycin decreases the functional shift to a slow phenotype induced by electrical stimulation in engineered muscle. Tissue Eng Part A 21:1003–1012
248. Khodabukus A, Baehr LM, Bodine SC, Baar K (2015) Role of Contraction Duration in Inducing Fast-To-Slow Contractile and Metabolic Protein and Functional Changes in Engineered Muscle. J Cell Physiol
249. Khodabukus A, Baar K (2012) Defined electrical stimulation emphasizing excitability for the development and testing of engineered skeletal muscle. Tissue Eng Part C Methods 18:349–357
250. Donnelly K, Khodabukus A, Philp A, Deldicque L, Dennis RG, Baar K (2010) A novel bioreactor for stimulating skeletal muscle in vitro. Tissue Eng Part C Methods 16:711–718
251. Ito A, Yamamoto Y, Sato M, Ikeda K, Yamamoto M, Fujita H et al (2014) Induction of functional tissue-engineered skeletal muscle constructs by defined electrical stimulation. Sci Rep 4:4781
252. Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J et al (1997) Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 11:683–694
253. Bursac N, Papadaki M, Cohen RJ, Schoen FJ, Eisenberg SR, Carrier R et al (1999) Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 277:H433–H444
254. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM (1999) Survival and function of bioengineered cardiac grafts. Circulation 100:II63–II69
255. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A et al (2000) Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102:III56-II61
256. Kofidis T, Akhyari P, Wachsmann B, Boublik J, Mueller-Stahl K, Leyh R et al (2002) A novel bioartificial myocardial tissue and its prospective use in cardiac surgery. Eur J Cardiothorac Surg 22:238–243
257. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 68:106–114
258. Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF et al (2002) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90:223–230
259. Shimizu T, Yamato M, Isoi Y, Akutsu T, Setomaru T, Abe K et al (2002) Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 90:e40
260. Baar K, Birla R, Boluyt MO, Borschel GH, Arruda EM, Dennis RG (2005) Self-organization of rat cardiac cells into contractile 3-D cardiac tissue. Faseb J. 19:275–277
261. Black LD, Meyers JD, Weinbaum JS, Shvelidze YA, Tranquillo RT (2009) Cell-induced alignment augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue Eng Part A
262. Hirt MN, Sorensen NA, Bartholdt LM, Boeddinghaus J, Schaaf S, Eder A et al (2012) Increased afterload induces pathological cardiac hypertrophy: a new in vitro model. Basic Res Cardiol 107:307
263. Tao ZW, Mohamed M, Hogan M, Gutierrez L, Birla RK (2014) Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel. J Tissue Eng Regen Med
264. Bian W, Jackman CP, Bursac N (2014) Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication 6:024109
265. Bian W, Liau B, Badie N, Bursac N (2009) Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc 4:1522–1534
266. Solaro RJ, Lee JA, Kentish JC, Allen DG (1988) Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ Res 63:779–787
267. Raman S, Kelley MA, Janssen PM (2006) Effect of muscle dimensions on trabecular contractile performance under physiological conditions. Pflugers Arch 451:625–630
268. Radisic M, Fast VG, Sharifov OF, Iyer RK, Park H, Vunjak-Novakovic G (2009) Optical mapping of impulse propagation in engineered cardiac tissue. Tissue Eng Part A 15:851–860
269. Sondergaard CS, Mathews G, Wang L, Jeffreys A, Sahota A, Wood M et al (2012) Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue. The Annals of thoracic surgery 94:1241–1248 (discussion 9)
270. Bursac N, Loo Y, Leong K, Tung L (2007) Novel anisotropic engineered cardiac tissues: studies of electrical propagation. Biochem Biophys Res Commun 361:847–853
271. Shimizu T, Sekine H, Isoi Y, Yamato M, Kikuchi A, Okano T (2006) Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng 12:499–507
272. Bian W, Badie N, Himel HDt, Bursac N (2014) Robust T-tubulation and maturation of cardiomyocytes using tissue-engineered epicardial mimetics. Biomaterials 35:3819–3828
273. Nygren A, Kondo C, Clark RB, Giles WR (2003) Voltage-sensitive dye mapping in Langendorff-perfused rat hearts. Am J Physiol Heart Circ Physiol 284:H892–H902
274. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U et al (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12:452–458
275. Godier-Furnemont AF, Tiburcy M, Wagner E, Dewenter M, Lammle S, El-Armouche A et al (2015) Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation. Biomaterials 60:82–91
276. Liau B, Christoforou N, Leong KW, Bursac N (2011) Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 32:9180–9187
277. Masumoto H, Matsuo T, Yamamizu K, Uosaki H, Narazaki G, Katayama S et al (2012) Pluripotent stem cell-engineered cell sheets reassembled with defined cardiovascular populations ameliorate reduction in infarct heart function through cardiomyocyte-mediated neovascularization. Stem Cells 30:1196–1205
278. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, Higuchi T et al (2012) Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med 1:430–437
279. Didie M, Christalla P, Rubart M, Muppala V, Doker S, Unsold B et al (2013) Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Investig 123:1285–1298
280. Christoforou N, Liau B, Chakraborty S, Chellapan M, Bursac N, Leong KW (2013) Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues. PLoS One 8:e65963
281. Hirt MN, Hansen A, Eschenhagen T (2014) Cardiac tissue engineering: state of the art. Circ Res 114:354–367
282. Kerscher P, Turnbull IC, Hodge AJ, Kim J, Seliktar D, Easley CJ et al (2015) Direct Hydrogel Encapsulation of Pluripotent Stem Cells Enables Ontomimetic Differentiation and Growth of Engineered Human Heart Tissues. Biomaterials
283. Riegler J, Tiburcy M, Ebert A, Tzatzalos E, Raaz U, Abilez OJ et al (2015) Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model. Circ Res 117:720–730
284. Eng G, Lee BW, Protas L, Gagliardi M, Brown K, Kass RS et al (2016) Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat Commun 7:10312
285. Guyette JP, Charest J, Mills RW, Jank B, Moser PT, Gilpin SE et al (2015) Bioengineering Human Myocardium on Native Extracellular Matrix. Circ Res
286. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD et al (2011) Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 109:47–59
287. Zhang D, Shadrin IY, Lam J, Xian HQ, Snodgrass HR, Bursac N (2013) Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34:5813–5820
288. Kensah G, Roa Lara A, Dahlmann J, Zweigerdt R, Schwanke K, Hegermann J et al (2013) Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J 34:1134–1146
289. Thavandiran N, Dubois N, Mikryukov A, Masse S, Beca B, Simmons CA et al (2013) Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proc Natl Acad Sci USA 110:E4698–E4707
290. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR (1992) Altered myocardial force-frequency relation in human heart failure. Circulation 85:1743–1750
291. Hasenfuss G, Mulieri L, Blanchard E, Holubarsch C, Leavitt B, Ittleman F et al (1991) Energetics of isometric force development in control and volume- overload human myocardium. Comparison with animal species. Circ Res 68:836–846
292. Durrer D, van Dam RT, Freud GE, Janse MJ, Meijler FL, Arzbaecher RC (1970) Total excitation of the isolated human heart. Circulation 41:899–912
293. Yang X, Pabon L, Murry CE (2014) Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 114:511–523
294. Feric NT, Radisic M (2015) Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev
295. Yang X, Rodriguez M, Pabon L, Fischer KA, Reinecke H, Regnier M et al (2014) Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. J Mol Cell Cardiol 72:296–304
296. Rangarajan S, Madden L, Bursac N (2014) Use of flow, electrical, and mechanical stimulation to promote engineering of striated muscles. Ann Biomed Eng 42:1391–1405
297. Lundy SD, Zhu W-Z, Regnier M, Laflamme MA (2013) Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22:1991–2002
298. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J et al (2013) Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J Off J Japn Circ Soc 77:1307–1314
299. Hirt MN, Boeddinghaus J, Mitchell A, Schaaf S, Börnchen C, Müller C et al (2014) Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation. J Mol Cell Cardiol 74:151–161
300. Nunes SS, Miklas JW, Liu J, Aschar-Sobbi R, Xiao Y, Zhang B et al (2013) Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods 10:781–787
301. Zhang Y, King OD, Rahimov F, Jones TI, Ward CW, Kerr JP et al (2014) Human skeletal muscle xenograft as a new preclinical model for muscle disorders. Hum Mol Genet 23:3180–3188
302. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC et al (2005) Engineering vascularized skeletal muscle tissue. Nat Biotechnol 23:879–884
303. Koffler J, Kaufman-Francis K, Shandalov Y, Egozi D, Pavlov DA, Landesberg A et al (2011) Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc Natl Acad Sci USA 108:14789–14794
304. Kajbafzadeh AM, Payabvash S, Salmasi AH, Sadeghi Z, Elmi A, Vejdani K et al (2007) Time-dependent neovasculogenesis and regeneration of different bladder wall components in the bladder acellular matrix graft in rats. J Surg Res 139:189–202
305. Criswell TL, Corona BT, Wang Z, Zhou Y, Niu G, Xu Y et al (2013) The role of endothelial cells in myofiber differentiation and the vascularization and innervation of bioengineered muscle tissue in vivo. Biomaterials 34:140–149
306. Borschel GH, Dow DE, Dennis RG, Brown DL (2006) Tissue-engineered axially vascularized contractile skeletal muscle. Plast Reconstr Surg 117:2235–2242
307. Mian R, Morrison WA, Hurley JV, Penington AJ, Romeo R, Tanaka Y et al (2000) Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng 6:595–603
308. Messina A, Bortolotto SK, Cassell OC, Kelly J, Abberton KM, Morrison WA (2005) Generation of a vascularized organoid using skeletal muscle as the inductive source. Faseb J. 19:1570–1572
309. Bach AD, Arkudas A, Tjiawi J, Polykandriotis E, Kneser U, Horch RE et al (2006) A new approach to tissue engineering of vascularized skeletal muscle. J Cell Mol Med 10:716–726
310. Shandalov Y, Egozi D, Koffler J, Dado-Rosenfeld D, Ben-Shimol D, Freiman A et al (2014) An engineered muscle flap for reconstruction of large soft tissue defects. Proc Natl Acad Sci USA 111:6010–6015
311. Dhawan V, Lytle IF, Dow DE, Huang YC, Brown DL (2007) Neurotization improves contractile forces of tissue-engineered skeletal muscle. Tissue Eng 13:2813–2821
312. Zhou W, He DQ, Liu JY, Feng Y, Zhang XY, Hua CG et al (2013) Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects. J Tissue Eng Regen Med
313. Shvartsman D, Storrie-White H, Lee K, Kearney C, Brudno Y, Ho N et al (2014) Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol Ther 22:1243–1253
314. Lu Y, Shansky J, Del Tatto M, Ferland P, Wang X, Vandenburgh H (2001) Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104:594–599
315. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW et al (2010) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci USA 107:3287–3292
316. Borselli C, Cezar CA, Shvartsman D, Vandenburgh HH, Mooney DJ (2011) The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials 32:8905–8914
317. Fuoco C, Rizzi R, Biondo A, Longa E, Mascaro A, Shapira-Schweitzer K et al (2015) In vivo generation of a mature and functional artificial skeletal muscle. EMBO Mol Med 7:411–422
318. Gargioli C, Coletta M, De Grandis F, Cannata SM, Cossu G (2008) PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med 14:973–978
319. Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S et al (2010) Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A 16:115–125
320. Sekine H, Shimizu T, Hobo K, Sekiya S, Yang J, Yamato M et al (2008) Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118:S145–S152
321. Masumoto H, Ikuno T, Takeda M, Fukushima H, Marui A, Katayama S et al (2014) Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep 4:6716
322. Stevens KR, Kreutziger KL, Dupras SK, Korte FS, Regnier M, Muskheli V et al (2009) Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc Natl Acad Sci USA 106:16568–16573
323. Sun X, Altalhi W, Nunes SS (2015) Vascularization strategies of engineered tissues and their application in cardiac regeneration. Adv Drug Deliv Rev
324. Xiong Q, Hill KL, Li Q, Suntharalingam P, Mansoor A, Wang X et al (2011) A fibrin patch-based enhanced delivery of human embryonic stem cell-derived vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem Cells 29:367–375
325. Thomson KS, Korte FS, Giachelli CM, Ratner BD, Regnier M, Scatena M (2013) Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications. Tissue Eng Part A 19:967–977
326. Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, Landa N et al (2009) Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci USA 106:14990–14995
327. Gerbin KA, Yang X, Murry CE, Coulombe KL (2015) Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts. PLoS One 10:e0131446
328. Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Cacciapuoti I et al (2015) Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Euro Heart J
329. Miyagawa S, Sawa Y, Sakakida S, Taketani S, Kondoh H, Memon IA et al (2005) Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: their integration with recipient myocardium. Transplantation 80:1586–1595
330. Sekine H, Shimizu T, Dobashi I, Matsuura K, Hagiwara N, Takahashi M et al (2011) Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A
331. Fujimoto KL, Clause KC, Liu LJ, Tinney JP, Verma S, Wagner WR et al (2011) Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Eng Part A 17:585–596
332. Wendel JS, Ye L, Zhang P, Tranquillo RT, Zhang JJ (2014) Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model. Tissue Eng Part A 20:1325–1335
333. Marsano A, Maidhof R, Luo J, Fujikara K, Konofagou EE, Banfi A et al (2013) The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction. Biomaterials 34:393–401
334. Leontyev S, Schlegel F, Spath C, Schmiedel R, Nichtitz M, Boldt A et al (2013) Transplantation of engineered heart tissue as a biological cardiac assist device for treatment of dilated cardiomyopathy. Eur J Heart Fail 15:23–35
335. Chen YL, Sun CK, Tsai TH, Chang LT, Leu S, Zhen YY et al (2015) Adipose-derived mesenchymal stem cells embedded in platelet-rich fibrin scaffolds promote angiogenesis, preserve heart function, and reduce left ventricular remodeling in rat acute myocardial infarction. Am J Trans Res 7:781–803
336. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T et al (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:S29–S37
337. Mihic A, Li J, Miyagi Y, Gagliardi M, Li S-H, Zu J et al (2014) The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 35:2798–2808
338. Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J et al (2013) Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation 127:997–1008
339. Simpson DL, Dudley SC Jr (2013) Modulation of human mesenchymal stem cell function in a three-dimensional matrix promotes attenuation of adverse remodelling after myocardial infarction. J Tissue Eng Regen Med 7:192–202
340. Roura S, Soler-Botija C, Bago JR, Llucia-Valldeperas A, Fernandez MA, Galvez-Monton C et al (2015) Postinfarction Functional recovery driven by a three-dimensional engineered fibrin patch composed of human umbilical cord blood-derived mesenchymal stem cells. Stem Cells Trans Med 4:956–966
341. VanDusen KW, Syverud BC, Williams ML, Lee JD, Larkin LM (2014) Engineered skeletal muscle units for repair of volumetric muscle loss in the tibialis anterior muscle of a rat. Tissue Eng Part A 20:2920–2930
342. Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E et al (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400–403
343. Tabebordbar M, Zhu K, Cheng JK, Chew WL, Widrick JJ, Yan WX et al (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407–411
344. Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM et al (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351:403–407
345. Wright AV, Nunez JK, Doudna JA (2016) Biology and applications of CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 164:29–44
346. Shuman JA, Zurcher JR, Sapp AA, Burdick JA, Gorman RC, Gorman JH 3rd et al (2013) Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med 23:301–311
347. Sakellariou P, O’Neill A, Mueller AL, Stadler G, Wright WE, Roche JA et al (2015) Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts. Skelet Muscle 6:4
348. Kirkton RD, Bursac N (2011) Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. Nat Commun 2:300